Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2014-02-01 (12 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAUCATS (33650), Gironde
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE PRINCIPALE DE SAUCATS : revenue, balance sheet and financial ratios
PHARMACIE PRINCIPALE DE SAUCATS is a French company
founded 12 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAUCATS (33650),
this company of category PME
shows in 2022 a revenue of 2.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE PRINCIPALE DE SAUCATS (SIREN 803511781)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
2 116 159 €
N/C
N/C
N/C
N/C
N/C
Net income
130 594 €
117 218 €
150 018 €
214 365 €
161 331 €
91 835 €
130 859 €
142 790 €
150 562 €
EBITDA
N/C
N/C
N/C
305 256 €
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
10.1%
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE PRINCIPALE DE SAUCATS generates positive net income of 131 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 151 k€ -> 131 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
130 594 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 392%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 18%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
392.438%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
18.436%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE PRINCIPALE DE SAUCATS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
105.167
74.33
53.733
34.131
31.758
30.832
26.491
26.571
392.438
Financial autonomy
43.594
51.805
58.568
66.788
66.909
65.185
67.549
69.981
18.436
Repayment capacity
None
None
None
None
None
1.537
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
10.403%
None%
None%
None%
Sector positioning
Debt ratio
392.442025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average+47 pts over 3 years
In 2025, the debt ratio of PHARMACIE PRINCIPALE DE S... (392.44) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
18.44%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Watch-49 pts over 3 years
In 2025, the financial autonomy of PHARMACIE PRINCIPALE DE S... (18.4%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 524.30. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
524.301
Liquidity indicators evolution PHARMACIE PRINCIPALE DE SAUCATS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
218.896
260.65
284.274
251.105
231.839
209.363
199.048
219.357
524.301
Interest coverage
None
None
None
None
None
2.855
None
None
None
Sector positioning
Liquidity ratio
524.32025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Excellent+22 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE PRINCIPALE DE S... (524.30) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 44 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 927 days. Excellent situation: suppliers finance 883 days of the operating cycle (retail model).
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
44 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
927 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE PRINCIPALE DE SAUCATS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
195 152 €
0 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
28
0
0
0
Customer payment term (days)
0
0
144
71
82
4
35
42
44
Supplier payment term (days)
0
0
687
535
688
48
980
772
927
Positioning of PHARMACIE PRINCIPALE DE SAUCATS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE PRINCIPALE DE SAUCATS is estimated at
2 074 501 €
(range 1 407 766€ - 3 255 178€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1407k€2074k€3255k€
2 074 501 €Range: 1 407 766€ - 3 255 178€
NAF 5 année 2025
Valuation method used
Net Income Multiple
130 594 €
×
15.9x
=2 074 501 €
Range: 1 407 766€ - 3 255 178€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE PRINCIPALE DE SAUCATS with other companies in the same sector:
Frequently asked questions about PHARMACIE PRINCIPALE DE SAUCATS
What is the revenue of PHARMACIE PRINCIPALE DE SAUCATS ?
The revenue of PHARMACIE PRINCIPALE DE SAUCATS in 2022 is 2.1 M€.
Is PHARMACIE PRINCIPALE DE SAUCATS profitable?
Yes, PHARMACIE PRINCIPALE DE SAUCATS generated a net profit of 131 k€ in 2025.
Where is the headquarters of PHARMACIE PRINCIPALE DE SAUCATS ?
The headquarters of PHARMACIE PRINCIPALE DE SAUCATS is located in SAUCATS (33650), in the department Gironde.
Where to find the tax return of PHARMACIE PRINCIPALE DE SAUCATS ?
The tax return of PHARMACIE PRINCIPALE DE SAUCATS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE PRINCIPALE DE SAUCATS operate?
PHARMACIE PRINCIPALE DE SAUCATS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart